Secondary Logo

Journal Logo

August 2006 - Volume 29 - Issue 4
pp: 325-425


Thoracic


Gemcitabine, Ifosfamide, and Cisplatin Combination (GIP) in Treatment of Patients With Locally Advanced or Metastatic Nonsmall Cell Lung Cancer: Results of a Phase II Study

Planchard, David; Bourgeois, Hugues; Adoun, Michèle; More

American Journal of Clinical Oncology. 29(4):345-351, August 2006.

Cutaneous


Peptide Vaccination of Patients With Metastatic Melanoma: Improved Clinical Outcome in Patients Demonstrating Effective Immunization

Markovic, Svetomir N.; Suman, Vera J.; Ingle, James N.; More

American Journal of Clinical Oncology. 29(4):352-360, August 2006.

Hematopoeitic


Gastrointestinal


Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV) in Patients With Metastatic Gastric Cancer (MGC)

Cavanna, Luigi; Artioli, Fabrizio; Codignola, Claudio; More

American Journal of Clinical Oncology. 29(4):371-375, August 2006.

Breast


Paclitaxel and Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil for Patients With Stage IIIC Breast Cancer With Ten or More Involved Axillary Lymph Nodes

Battelli, Nicola; Massacesi, Cristian; Braconi, Chiara; More

American Journal of Clinical Oncology. 29(4):380-384, August 2006.

Estrogen Receptors Evolution in Neoadjuvant Aromatase Inhibitor (AI) Therapy For Breast Cancer in Elderly Women: Stability of Hormonal Receptor Expression During Treatment

Salmon, R J.; Alran, S; Malka, I; More

American Journal of Clinical Oncology. 29(4):385-388, August 2006.

Genitourinary


Phase II Evaluation of Docetaxel Plus Exisulind in Patients With Androgen Independent Prostate Carcinoma

Sinibaldi, Victoria J.; Elza-Brown, Kathy; Schmidt, Jill; More

American Journal of Clinical Oncology. 29(4):395-398, August 2006.

Developmental Therapeutics


Research Methods